Latest News in the pharma Industry
Research & Development
Collaboration to develop innovative technologies
20 Dec 2017
Project will innovate technologies in epigenetic characterisation for patient stratification in renowned precision medicine.
Read more
NIH study uncovers clues about why common cancer drug causes hearing loss
20 Dec 2017
Researchers find target to protect hearing during chemotherapy treatment.
Read more
Regeneron and ISA Pharma to advance immuno-oncology treatment
18 Dec 2017
Collaboration to conduct clinical trials of the combination treatment in both cervical and head-and-neck cancer.
Read more
Major breakthrough for new haemophilia A treatment
15 Dec 2017
Drug trials provide mind-blowing results.
Read more
New formulation of Oncaspar receives Marketing Authorization in Europe for patients with ALL
14 Dec 2017
Freeze-dried, or lyophilized, formulation aims to improve supply management by providing the same dosing regimen as liquid Oncaspar but with a three-times longer shelf life of up to 24 months.
Read more
CMC Biologics and Harpoon Therapeutics collaborate on exciting new TriTAC molecules
14 Dec 2017
First clinical candidate, HPN424, is in development for the treatment of metastatic prostate cancer and expected to enter Phase I clinical trials in 2018.
Read more
Sanofi ends development of Clostridium difficile vaccine
4 Dec 2017
IDMC concludes that the study is unlikely to meet its primary objective.
Read more.png)
Novartis' Ultibro Breezhaler significantly improved COPD patients' lung function after direct switch from Seretide
29 Nov 2017
Study provides further evidence that it is possible to reduce the burden of long-term inhaled steroids in many COPD patients.
Read more.jpg)
Company's new identity integrates services typically found in disparate CDMOs and CROs
20 Nov 2017
Quotient Sciences Translational Pharmaceutics platform integrates formulation development, real-time adaptive GMP manufacturing and clinical research.
Read more
New treatments to solve global antibiotic crisis could reach the market by 2020
19 Nov 2017
New ARB technology rejuvenates existing antibiotics to outsmart antibiotic resistance.
Read more.png)
Bavencio becomes first treatment for rare skin cancer mMCC licensed for use in the UK
7 Nov 2017
The launch of avelumab marks a step-change in the way that mMCC can be treated.
Read more.png)
Novartis seeks leadership with Cosentyx
6 Nov 2017
For the first time for any biologic, data show almost 80% of ankylosing spondylitis patients on Cosentyx have no radiographic progression of the spine at 4 years.
Read more